The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. Until today this year the stock’s price performance recorded an increase of 7.84%. However, over the last six months, the performance has been weaker by 17.68%. The price of DXCM increased 5.05% over the last 30 days. And in the last five days, it has fallen by -5.53%.
Dexcom Inc saw a rather unpredictable run in, in terms of market performance. The company’s stock reached its highest point at $142.00 on 03/26/24, while the lowest price for the same duration was marked at $62.34 on 07/26/24.
52-week price history of DXCM Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Dexcom Inc’s current trading price is -40.94% away from its 52-week high, while its distance from the 52-week low is 34.54%. The stock’s price range during this period has varied between$62.34 and $142.00. The Dexcom Inc’s shares, which operate in the Healthcare, saw a trading volume of around 4.11 million for the day, a figure considerably higher than their average daily volume of 3.44 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Dexcom Inc (DXCM) has experienced a quarterly rise of 19.88% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 32.76B and boasts a workforce of 9600 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 76.58, with a change in price of +14.41. Similarly, Dexcom Inc recorded 3,850,025 in trading volume during the last 100 days, posting a change of +20.75%.
DXCM’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for DXCM stands at 1.31. Similarly, the long-term debt-to-equity ratio is also 1.30.
DXCM Stock Stochastic Average
Dexcom Inc’s raw stochastic average for the past 50 days is presently 64.18%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 40.02%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 68.69% and 81.88%, respectively.
